Grants per year
Search results
-
Active
SB-913-1603: A Phase I, Multicenter, Open-label, Single-dose, Dose-ranging Study to Assess the Safety and Tolerability of SB-913, a rAAV2/6-based Gene Transfer in Subjects with Mucopolysaccharidosis II (MPS II)
Alden, T. D. (PD/PI), Burton, B. K. (PD/PI) & Mohammad, S. (PD/PI)
9/1/17 → 8/31/50
Project: Research project
-
The Park-Reeves Syringomyelia Registry and Data Use Agreement
Alden, T. D. (PD/PI), DiPatri, A. J. (PD/PI) & Tomita, T. (PD/PI)
1/18/13 → 8/31/50
Project: Research project
-
Finished
Posterior Fossa Decompression with or without Duraplasty for Chiari Type I Malformation with Syringomyelia
Alden, T. D. (PD/PI), Bowman, R. (PD/PI), DiPatri, A. J. (PD/PI) & Tomita, T. (PD/PI)
Washington University, Patient-Centered Outcomes Research Institute
12/1/15 → 12/31/18
Project: Research project
-
Posterior Fossa Decompression with or without Duraplasty for Chiari Type I Malformation with Syringomyelia
Alden, T. D. (PD/PI), Bowman, R. (PD/PI), DiPatri, A. J. (PD/PI) & Tomita, T. (PD/PI)
Washington University, Washington University/ Subcontract
12/1/15 → 12/31/18
Project: Research project
-
AGT-182-101: A Phase 1 Safety and Dose-Finding Study of a Human Insulin Receptor Monoclonal Antibody-Human Iduronate 2-Sulfatase (IDS) Fusion Protein, AGT-182 in Adult Patients with Mucopolysaccharidosis II (MPS II, Hunter Syn
Burton, B. K. (PD/PI), Alden, T. D. (Co-Investigator), Charrow, J. (Co-Investigator) & Epstein, L. G. (Co-Investigator)
10/1/15 → 10/1/16
Project: Research project
-
AGT-181-102: A Phase 1 Safety and Dose-Finding Study of a Human Insulin Receptor Monoclonal Antibody-Human alpha-L-iduronidase (HIRMAb-IDUA) Fusion Protein, AGT-181 in Adult Patients with Mucopolysaccharidosis I (MPS I)
Burton, B. K. (PD/PI), Alden, T. D. (Co-Investigator) & Charrow, J. (Co-Investigator)
9/24/15 → 12/31/16
Project: Research project
-
SHP-609-302: An Open Label Extension of Study HGT-HIT-094 Evaluating Long Term Safety and Clinical Outcomes of Intrathecal Idursulfase Administered in Conjunction with Elaprase® in Patients with Hunter Syndrome and Cognitive Im
Alden, T. D. (PD/PI), Burton, B. K. (PD/PI), Charrow, J. (PD/PI) & Rinaldi, J. A. (PD/PI)
Shire Human Genetic Therapies, Inc.
6/15/15 → 12/31/19
Project: Research project
-
HGT-HIT-046: An Open-Label Extension of Study HGT-HIT-045 Evaluating Long-Term Safety and Clinical Outcomes of Intrathecal Idursulfase-IT Administered inConjunction with Intravenous Elaprase® in Pediatric Patients with Hunter
Alden, T. D. (PD/PI), Burton, B. K. (PD/PI) & Charrow, J. (PD/PI)
Shire Human Genetic Therapies, Inc.
11/24/14 → 12/31/16
Project: Research project
-
HGT-HIT-094: A Controlled, Randomized, Two-arm, Open-label, Assessor-blinded, Multicenter Study of Intrathecal Idursulfase-IT Administered in Conjunction with Elaprase® in Pediatric Patients with Hunter Syndrome and Early Cogni
Alden, T. D. (PD/PI), Burton, B. K. (PD/PI), Charrow, J. (PD/PI) & Rinaldi, J. A. (PD/PI)
Shire Human Genetic Therapies, Inc.
4/21/14 → 10/9/18
Project: Research project